Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells

Aviezer, 1994, Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis, Cell, 79, 1005, 10.1016/0092-8674(94)90031-0 Battaglia, 1993, Structural basis of beta-1 integrin-mediated cell adhesion to a large heparan sulfate proteoglycan from basement membranes, Eur. J. Cell Biol., 61, 92 Battaglia, 1992, Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core, Eur. J. Biochem., 208, 359, 10.1111/j.1432-1033.1992.tb17195.x Blum, 1987, Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels, Electrophoresis, 8, 93, 10.1002/elps.1150080203 Brown, 1997, The C-terminal Domain V of perlecan promotes β1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans, Eur. J. Biochem., 250, 39, 10.1111/j.1432-1033.1997.t01-1-00039.x Chakravarti, 1995, Recombinant Domain III of perlecan promotes cell attachment through its RGDS sequence, J. Biol. Chem., 270, 404, 10.1074/jbc.270.1.404 Cockerill, 1994, Characterization of a spontaneously transformed human endothelial cell line, Lab. Invest., 71, 497 Costell, 1997, Characterization of recombinant perlecan Domain I and its substitution by glycosaminoglycans and oligosaccharides, Eur. J. Biochem., 243, 115, 10.1111/j.1432-1033.1997.t01-1-00115.x Couchman, 1996, Perlecan and basement membrane-chondroitin sulfate proteoglycan (Bamacan) are two basement membrane chondroitin dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix, J. Biol. Chem., 271, 9595, 10.1074/jbc.271.16.9595 David, 1992, Developmental changes in heparan sulfate expression: In situ detection with mAbs, J. Cell Biol., 119, 961, 10.1083/jcb.119.4.961 Dolan, 1997, Identification of sites in Domain I of perlecan that regulate heparan sulfate synthesis, J. Biol. Chem., 272, 4316, 10.1074/jbc.272.7.4316 Fazekas de St Groth, S., 1979. The quality of antibodies and cellular receptors. In: Lefkovits, I., Pernis, B. (Eds.), Immunological Methods. Academic Press, pp. 1–42. Gauer, 1996, Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin, Eur. J. Cell Biol., 70, 233 Gohring, 1988, Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope, Eur. J. Biochem., 255, 60, 10.1046/j.1432-1327.1998.2550060.x Graham, L.D., 1998. Recombinant expression of individual domains from multifunctional proteins. In: Recent Research Developments in Biotechnology and Bioengineering., Research Signpost, Trivandrum, India, pp. 151–165. Groffen, 1996, Expression and characterization of human perlecan Domains I and II synthesized by baculovirus-infected insect cells, Eur. J. Biochem., 241, 827, 10.1111/j.1432-1033.1996.00827.x Hagen, 1993, Immunochemical and biochemical evidence for distinct basement membrane heparan sulfate proteoglycans, J. Biol. Chem., 268, 7261, 10.1016/S0021-9258(18)53171-9 Handler, 1997, Developmental expression of perlecan during murine embryogenesis, Dev. Dynam., 210, 130, 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H Hassell, 1980, Isolation of a heparan sulfate-containing proteoglycan from basement membrane, Proc. Natl. Acad. Sci. USA, 77, 4494, 10.1073/pnas.77.8.4494 Hayashi, 1992, Endothelial cells interact with the core protein of basement membrane perlecan through β1 and β3 integrins — an adhesion modulated by glycosaminoglycan, J. Cell Biol., 119, 945, 10.1083/jcb.119.4.945 Heremans, 1988, Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts, J. Biol. Chem., 263, 4731, 10.1016/S0021-9258(18)68844-1 Heremans, 1990, The core protein of the matrix-associated heparin sulphate proteoglycan binds to fibronectin, J. Biol. Chem., 265, 8716, 10.1016/S0021-9258(19)38948-3 Hiscock, 1995, Molecular structure of heparan sulfate synthesised by bovine aortic endothelial cells, Biochim. Biophys. Acta., 1244, 104, 10.1016/0304-4165(94)00206-D Iozzo, 1984, Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface, J. Cell. Biol., 99, 403, 10.1083/jcb.99.2.403 Iozzo, 1989, Identification of the precursor protein for the heparan sulfate proteoglycan of human colon carcinoma cells and its post-translational modifications, Arch. Biochem. Biophys., 269, 239, 10.1016/0003-9861(89)90105-7 Isemura, 1987, Isolation and characterisation of fibronectin-binding proteoglycan carrying both heparan sulfate and dermatan sulfate chains from human placenta, J. Biol. Chem., 262, 8926, 10.1016/S0021-9258(18)47503-5 Kellerman, 1982, Maltose-binding protein from Escherichia coli, Meth. Enzymol., 90, 459, 10.1016/S0076-6879(82)90171-9 Klein, 1995, Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells, Matrix Biol., 14, 457, 10.1016/0945-053X(95)90003-9 Kokenyesi, 1995, Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant Domain I of mouse perlecan expressed in Chinese hamster ovary cells, Biochem. Biophys. Res. Commun., 211, 262, 10.1006/bbrc.1995.1805 Kueng, 1989, Quantification of cells cultured on 96-well plates, Analyt. Biochem., 182, 16, 10.1016/0003-2697(89)90710-0 Lindblom, 1991, Domain structure of endothelial heparan sulfate, Biochem. J., 279, 821, 10.1042/bj2790821 Matthias, 1996, Identification of monoclonal antibodies that recognize different disulfide bonded forms of thrombospondin 1, Biochim. Biophys. Acta., 1296, 138, 10.1016/0167-4838(96)00060-X McDevitt, 1971, Gel electrophoresis of proteoglycans and glycosaminoglycans on large pore composite polyacrylamide–agarose gels, Anal. Biochem., 44, 612, 10.1016/0003-2697(71)90250-8 Molist, 1997, Enterocytic differentiation correlates with changes in the fine structure and sulfation of perlecan in HT29 human colon carcinoma cells, Biochem. Biophys. Res. Commun., 238, 874, 10.1006/bbrc.1997.7192 Morris, 1994, Relative topography of biologically active domains of human vitronectin, J. Biol. Chem., 269, 23845, 10.1016/S0021-9258(17)31592-2 Murdoch, 1992, Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan) — a chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor, J. Biol. Chem., 267, 8544, 10.1016/S0021-9258(18)42478-7 Murdoch, 1994, Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against Domain III and by in situ hybridization, J. Histochem. Cytochem., 42, 239, 10.1177/42.2.7507142 Noonan, 1991, The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin-a chain, low density lipoprotein-receptor, and the neural cell adhesion molecule, J. Biol. Chem., 266, 22939, 10.1016/S0021-9258(18)54445-8 Paulsson, 1987, Structure of low density heparan sulfate proteoglycan isolated from a mouse tumor basement membrane, J. Mol. Biol., 197, 297, 10.1016/0022-2836(87)90125-2 Riggs, P., 1990. Vectors for expression of foreign proteins in Escherichia coli by fusion to maltose-binding protein. In: Ausbel (Ed.), Current Protocols in Molecular Biology, Greene Assoc./Wiley Interscience., New York, pp. Saku, 1989, Characterisation of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture, J. Biol. Chem., 264, 3514, 10.1016/S0021-9258(18)94096-2 Schulze, 1996, Structural and cell-adhesive properties of three recombinant fragments derived from perlecan Domain III, Matrix Biol., 15, 349, 10.1016/S0945-053X(96)90138-9 Sephel, 1996, Expression of capillary basement membrane components during sequential phases of wound angiogenesis, Matrix Biol., 15, 263, 10.1016/S0945-053X(96)90117-1 Towbin, 1979, Electrophoretic transfer of proteins from polyacrylamide gells to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA, 76, 4350, 10.1073/pnas.76.9.4350 Turnbull, 1992, Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate, J. Biol. Chem., 267, 10337, 10.1016/S0021-9258(19)50023-0 Underwood, 1989, A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin, J. Cell Sci., 93, 641, 10.1242/jcs.93.4.641 Underwood, 1992, Anti-fibronectin antibodies that modify heparin binding and cell adhesion: evidence for a new cell binding site in the heparin binding region, J. Cell Sci., 102, 833, 10.1242/jcs.102.4.833 Underwood, 1983, Use of protein a to remove immunoglobulins from serum in hybridoma culture media, J. Immun. Meth., 60, 33, 10.1016/0022-1759(83)90332-0 Underwood, 1991, Practical limitations of estimation of protein adsorption to polymer surfaces, J. Immunol. Meth., 142, 83, 10.1016/0022-1759(91)90295-Q Vigny, 1988, Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor, J. Cell. Physiol., 137, 321, 10.1002/jcp.1041370216 Vischer, 1997, Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells Eur, J. Cell Biol., 73, 332 Weiser, 1997, Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells, Mol. Biol. Cell, 8, 999, 10.1091/mbc.8.6.999 Whitelock, 1997, The effect of human endothelial cell-derived proteoglycans on human smooth muscle cell growth, Cell Biol. Int., 21, 181, 10.1006/cbir.1996.0125 Whitelock, 1996, The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases, J. Biol. Chem., 271, 10079, 10.1074/jbc.271.17.10079